“Six MGHers have been named to Cell Mentor’s list of 1,000 Inspiring Black Scientists in America. They are: David Alagpulinsa, PhD, research fellow in the Infectious Disease Unit; Emery N. Brown, MD, PhD, director of the Neuroscience Statistic Research Laboratory in the Department of Anesthesia, Critical Care and Pain Medicine; Sherri-Ann Burnett-Bowie, MD, MPH, associate director of the MGH Center for Diversity and Inclusion; Jonathan Jackson, PhD, founder and executive director of the Community Access, Recruitment & Engagement (CARE); Victoria Parker, PhD, research fellow in Radiology; and Camille Powe, MD, endocrinologist and co-director of the MGH Diabetes in Pregnancy Program. This list was created to compel and imbue the next generation of Black scientists and other minoritized individuals to enhance and empower our culture’s dignity.”
Dr. Poznansky on Sirius XM Canada Talks
The Biden administration is already quickly working on a vaccine strategy for distribution in the United States. Mass General Hospital’s Dr. Mark Poznansky spoke with @SXMCanadaTalks host Matt Gurney about what the timelines could look like. Dr. Poznansky says he’s optimistic and that while “it’s never fast enough given the pandemic curve we’re on at the moment, at least it’s happening step-by-step.
Vaccine and Immunotherapy Center MGH 2020 Holiday Newsletter
Dear Family and Friends of VIC,
This has been a difficult year. With your help VIC has risen to the challenge by pivoting to address COVID-19 while continuing uninterrupted by the pandemic to develop new vaccines and immunotherapies for cancer, infectious and immune mediated diseases.
Several of our key achievements in 2020 are outlined below but please read the attached for more detail on VIC scientists’ exciting research
- Rapidly modified our existing vaccine development platform to design and begin testing of a new vaccine for COVID-19, focused on inducing a strong T cell response. While we hope that large scale vaccine efforts are successful, evidence shows this approach will produce longer lasting protection
- Established new collaborative work with biotech companies to develop powerful new tools for COVID-19 testing
- Received rapid FDA approval for first in human testing of our novel B cell immunotherapy for the treatment of a patient with ALS
- Developed a new treatment for type 1 diabetes and demonstrated proof of principle in mouse model of the disease
We would like to thank all family and friends of VIC, old and new, including Analog Devices, UniFirst and New England Biolabs, who made donations this year and helped make the impossible possible. You all helped bring VIC successfully and impactfully through this very challenging year. We are grateful for your continued support into 2021.
A Very Happy Thanksgiving to All from,
Dr. Mark Poznansky, Dr. Ann Sluder & the VIC team
Philanthropic support is critical to VIC’s success
Remote Student Internship experiences at VIC during the unprecedented summer of 2020






COVID-19 infections trouble ships as companies try pandemic cruising in Europe, Tahiti
Michael Callahan, MD, Director, Clinical Translation at VIC, was deployed to cruise ships to provide emergency medical help during the COVID-19 outbreak earlier in the year and is now assisting with advice on continuity of business. The cruise ship articles in the Miami Herald, of which this is the latest, prompted a WHO Working Group to reduce international spread to which Michael has been invited.
It’s not over when the vaccine arrives
Mark Poznansky interviewed for a report on Axios.com by Alison Snyder and Sam Baker
Production, deployment among challenges when COVID-19 vaccine ready
Congratulations to David Alagpulinsa, PhD, Research Fellow at VIC
Congratulations to David Alagpulinsa, PhD, Research Fellow at VIC, for the 2020 Physician/Scientist Development Award, sponsored by the MGH Executive Committee on Research.
David will be using the award to further his research into type 1 diabetes – “Harnessing CXCL12 signaling for immunoprotection, survival and regeneration of pancreatic islets in type 1 diabetes”.

“The MGH Center for Diversity and Inclusion has honored five MGHers with their annual faculty development awards. Katia Canenguez, PhD, EdM, Department of Child and Adolescent Psychiatry, received the 2020 Clinician-Teacher Development Award, sponsored by the MGPO. David Alagpulinsa, PhD, Infectious Disease Unit fellow; Ibiayi Dagogo-Jack, MD, Cancer Center physician; Christian Lino Cardenas, PharmD, MSc, PhD, Cardiovascular Research Center fellow; and Nneka Ufere, MD, Gastroenterology fellow, received 2020 Physician/Scientist Development Awards, sponsored by the MGH Executive Committee on Research.”
What you should know about the race for a COVID-19 vaccine, treatment, and testing
“Boston is playing a big role in the long-term fight against COVID-19.
It is easy to take scientific progress for granted when the world is held hostage by a virus. While no one can guarantee we will develop a successful COVID-19 vaccine, the pace at which clinical research teams are working — and collaborating — is unprecedented.”
Recent Boston Globe Piece by: Jacqueline Lisk
How Fauci, 5 other health specialists deal with COVID-19 risks in their everyday lives
“As Americans learn to live with the coronavirus, many are struggling with decisions about which practices are safe or risky for them. The Washington Post asked six public health/infectious diseases specialists about their own behavior choices. Their responses have been edited for length and clarity…”